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Abstract
Purpose The identification of patients infected by SARS-CoV-2 is highly important to control the disease; however, the clinical
presentation is often unspecific and a large portion of the patients develop mild or no symptoms at all. For this reason, there is an
emphasis on evaluating diagnostic tools for screening. Chest CT scans are emerging as a useful tool in the diagnostic process of
viral pneumonia cases associated with COVID-19. This review examines the sensitivity, specificity, and feasibility of chest CT in
detecting COVID-19 compared with real-time polymerase chain reaction (RT-PCR).
Methods Sensitivity and specificity of chest CT in detecting COVID-19 in its various phases was compared using RT-PCR as a
gold standard. A “reverse calculation approach” was applied and treated chest CT as a hypothetical gold standard and compared
RT-PCR to it point out the flaw of the standard approach.
Results High sensitivity (67–100%) and relatively low specificity (25–80%) was reported for the CT scans. However, the
sensitivity of RT-PCR was reported to be modest (53–88%), hence cannot serve as an appropriate ground truth. The “reverse
calculation approach” showed that CT could have a higher specificity (83–100%) if we consider the modest sensitivity of the RT-
PCR.
Conclusions The sensitivity and specificity of the chest CT in diagnosing COVID-19 and the radiation exposure have to be
judged together. Arguments are presented that chest CT scans have added value in diagnosing COVID-19 especially in patients,
who exhibit typical clinical symptoms and have negative RT-PCR results in highly infected regions.
Key Points
• CT scans have higher specificity if we take into account the low sensitivity of the RT-PCR.
• Avoid chest CT as a sole diagnostic approach for COVID-19 infection.
• Patients who had negative RT-PCR result with typical clinical symptoms in highly infected regions or with close contact of
COVID-19-infected patients; the use of chest CT is warranted.
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Abbreviations
COVID-19 Coronavirus disease 2019
GGO Ground-glass opacity
RT-PCR Real-time polymerase chain reaction
SARS-CoV-2 Severe acute respiratory syndrome
coronavirus 2
Introduction
A novel coronavirus, named the severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2) was identified in 2019 in
China. The disease caused by the highly contagious virus is
called the coronavirus disease 2019 (COVID-19). It spread
over the world in a couple of months, causing high fatality
and enormous burden on the health care providers. The iden-
tification of the infected patients has a high importance to
control the disease. However the clinical picture might not
be helpful, since a large majority of patients are asymptomatic
or having only mild symptoms. Even if the patient had symp-
toms, those are rather unspecific (fever, cough, dyspnea).
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Consequently, the performance of various diagnostic tools
such as molecular biological tests and imaging are in the focus
of the current scientific interest. To date, one of the biggest
questions is where chest CT stands in the screening and diag-
nostic process in comparison with real-time polymerase chain
reaction (RT-PCR) test. In this paper, we try to summarize the
results available so far in this topic. We evaluate the available
data on the sensitivity, specificity, and accuracy of chest CT.
Appearance of the disease on the chest CT
The SARS-CoV-2 is a member of the family of
Coronaviridae and causes systemic and/or respiratory tract
infections, rarely acute respiratory distress syndrome, or
multi-organ failure. Its cellular entry is the angiotensin-
converting enzyme 2 receptor which is expressed partly on
the alveolar cells of the lung epithelium [1].
The CT manifestation of this viral pneumonia is non-
specific but it has characteristic features based on which
experienced radiologists can diagnose the disease.
Findings are similar to other viral pneumonias but the lo-
calization of the signs is rather typical (see Fig. 1). The
most frequent and earliest pattern is ground-glass opacity
(GGO) that at first may be unifocal, but usually multifocal,
bilateral, and peripheral distribution with a posterior pre-
dominance especially in inferior lobes. In the area of GGO,
common findings are the widening of vessels and traction
bronchiectasis [2].
The CT can be positive in the early phase, several days
after the onset of the opening symptom (0–4 days). Over time,
the CT findings change characteristically. In the progressive
stage (5–8 days), the affected areas usually grow and some-
times thickened interlobular and intralobular lines appear in-
side the GGO. This combination pattern is called crazy pav-
ing. It is not characteristic for other viral pneumonias; hence, it
can help the differential diagnosis [3].
The peak stage (9–13 days) is at about the 10th day.
Consolidation often appears mixed with or after GGO. It can
be seen as an early sign in elderly patients. The most severe
clinical status is acute respiratory distress syndrome, which is
radiologically equivalent to diffuse alveolar damage.
After that, in the absorption phase, organizing pneumonia
pattern appears, and fibrous stripes can be seen with reverse
halo sign and mild architectural distortion [3]. The abnormal-
ities resolve in about 1 month.
High sensitivity, but poor specificity of chest
CT in the diagnosis of symptomatic patients
One of the largest case series on the correlation of chest CT
and RT-PCR in COVID-19 is available from the epicenter of
the outbreak in Wuhan [4]. The 1014 patients were assigned
into three groups: The first two groups consisted of patients
having typical clinical symptoms and positive chest CT with
or without typical dynamic changes (81%). In the third group
(19%), the patients had only one positive CT scan and pre-
sumably clinical symptoms (Table 1).
Eighty-eight of all patients had a positive initial chest CT.
On the other hand, of all 1014 patients, only 601 (59%) had
positive RT-PCR results. In these patients, the chest CT was
positive in almost all cases (97%). In those patients who had
negative RT-PCR result, chest CT was positive in 75%. If the
authors considered the RT-PCR as a gold standard, the sensi-
tivity, specificity, and accuracy of chest CT indicating
COVID-19 infection were 97%, 25%, and 68%, respectively.
In another set of patients, also from Wuhan, 80 patients
with clinical symptoms and positive RT-PCRwere investigat-
ed. Chest CT was positive in 76 (sensitivity of 95%) patients
[5].
In a study from Shanghai, China, on 38 suspicious
COVID-19 patients (presumably all symptomatic), chest CT
showed a sensitivity of 100%, specificity of 25%, and accu-
racy 47% [7].
A study from a non-high-epidemic area of Japan analyzed
the results from 21 patients suspected to have COVID-19 at
CT scans at least 3 days after symptom onset [6]. Six patients
out of 21 had positive RT-PCR and 15 were proven to have
other causes of the symptoms (Moraxella, legionella,
pneumocystis, etc.). The sensitivity of the two raters was
67% and 83%, and the specificity 93% and 80%.
A study from Rome, Italy, also reported high sensitivity
(97%) but moderate specificity (56%) of chest CT in compar-
ison with RT-PCR in symptomatic patients [8]. Strengthening
their results, RT-PCR was repeated within 24 h if negative on
the first occasion.
Long presented data was from the city Yichang, China. In
the study out of 87 symptomatic patients, who had both RT-
PCR and chest CT performed, RT-PCR test was positive only
in 36 cases. Out of the 36 patients, chest CT was normal only
in one (sensitivity 97%) [9].
A recent meta-analysis, based on sixteen studies, calculated
a pooled sensitivity of 92%. In their review, the authors iden-
tified only two studies [4, 10] reporting specificity (25–33%).
Another meta-analysis found a pooled sensitivity of 94% and
specificity of 37% [11].
Sensitivity and specificity of RT-PCR
It was shown in a recent manuscript (submitted, not accepted
at the time of the drafting of this manuscript) that the perfor-
mance of the RT-PCR from various respiratory specimens is
modest. During the first 2 weeks after symptom onset, 74–
88% of sputum samples are positive and only 53–73% of the
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nasal swabs. Consequently, one might ask if RT-PCR can be
considered as a gold standard. In the following section, we
will re-evaluate the abovementioned studies as if the chest CT
with typical clinical presentation was the reference (Table 2).
This approach certainly underestimates the sensitivity of RT-
PCR and overestimates the specificity of chest CT because of
not considering other diseases having very similar clinical and
CT presentation. However, the traditional estimation consid-
ering the RT-PCR as a gold standard (see previous chapter)
might suffer from not considering the modest sensitivity of the
RT-PCR.
Starting with the largest study from Wuhan, if one con-
siders the chest CT as a gold standard, the sensitivity of RT-
PCR is 65%, the specificity is 83%, and the accuracy is 67%.
Considering Cheng’s study, if the chest CT was the refer-
ence, the sensitivity of PCR was only modest (47%) and ob-
viously specificity is high (100%). Similarly, on the Italian
sample, RT-PCR had a modest sensitivity and high specificity
[8].
The study of Himoto offers an in depth insight into the
performance of chest CT [6]. In this study, in the negative
RT-PCR patients, alternative diagnosis was established.
Fig. 1 Appearance of COVID-19
on CT. a, b A 35-year-old male
presented 13 days after the
symptom onset with unproductive
cough, fatigue, and anosmia. Mild
CT signs: GGOs in only one lobe.
c, d A 60-year-old male having
symptoms for 7 days: muscle
pain, weakness, fever, and effort
dyspnea. Bilateral, multilobar
GGOs and halo sign (small con-
solidation surrounded by GGO)
on the lower section. e, f A 73-
year-old woman experiencing
weakness, muscle pain, inappe-
tence, and mild effort dyspnea. e
Bilateral GGOs, thickened ves-
sels, and traction bronchiectasis
on the right. f 4 days later, the
abnormalities are more extensive
and crazy paving appeared within
the GGO. g, h An 82-year-old
man having symptoms for a
week: dry cough, fever, weak-
ness, inappetence, and low oxy-
gen saturation at presentation.
Several features are visible on the
CT scans: GGOs, consolidation,
organizing pneumonia with re-
verse halo sign
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Unfortunately, not all patients had RT-PCR test for COVID-
19 and only six of the 15 non-COVID patients had proven
infectious agent other than SARS-CoV-2.
The collaboration of radiologists from Changsha (Hunan
province of China) and Province, RI, USA, is providing a
picture probably closer to the truth [12]. The authors collected
chest CTs from 219 COVID-19 patients from China and 205
patients with positive Respiratory Pathogen Panel for viral
pneumonia from Province, RI, from a time period between
2017 and 2019 when no COVID-19 was reported in the
USA. The sensitivity for COVID-19 of the Chinese radiolo-
gists ranged from 72 to 94%, the specificity 24 to 94%, and the
accuracy 60 to 83%. In a smaller subsample of patients, US
radiologists had sensitivity of 70 to 93%, specificity of 93 to
100%, and accuracy of 84 to 97%.
Fang’s report from Eastern China showed that the sensitiv-
ity of the RT-PCRmight not be optimal at the beginning of the
disease. The first RT-PCR test performed in the first 3 (± 3)
days after symptom onset was positive in only 36 of the 51
patients. Further 12 patients had positive RT-PCR test on the
second occasion (24–48 h after the first), 2 patients by three
tests (2–5 days), and one patient by four tests (7 days). On the
other hand, 98% of the patients had positive chest CT scan on
the first occasion (36 patients with typical and 14with atypical
CT manifestations) [13]. Similarly, in Long’s report, there
were 36 patients having positive RT-PCR out of the 87 who
had been included in the study [9]. However, 6 cases were
missed on the first presentation with RT-PCR. Repeated RT-
PCR test 48–72 h later identified further 3 patients and retest
for the third time (5–8 days after the first) identified 3 patients.
Importantly, the initial CT scan was positive in all but one
patient. Therefore, the sensitivity of chest CT at the initial
presentation was 97.2% and the RT-PCR only 84.6%. The
importance of multiple RT-PCR tests were emphasized by
Xie too [14].
It also has to be noted that the evolution of signs of the
disease on chest CT is dynamic and peaks at around the 10th
day after the first symptoms appeared [3]. Furthermore, it is
also an important question when one should judge a chest CT
positive. The experience of the reading radiologist may also
influence the result diagnosing COVID-19. It is probably not a
binary decision, but more of a spectrum to which a cutoff
could be determined [15]; therefore, the already reported sen-
sitivity and specificity values can be fairly over or
underestimated. Similarly, the definition of positive chest
CT can also influence the provided performance of RT-PCR.
Chest CT in asymptomatic patients
The modest performance of RT-PCR testing raised the ques-
tion whether it could be used in the early, asymptomatic stage
of the disease and if chest CT could have an added value. Up
to date, only a few reports presented data on this topic. Hu and
co-workers showed that 50% of the asymptomatic SARS-
CoV-2-infected patients had typical ground-glass opacities
and further 20% atypical CT presentation [16]. Half of the
CT-positive patients never developed any symptoms. Lin
and colleagues reported about a patient having multiple
GGOs in the right lung and not having clinical symptoms
[17]. Later on, when the patient developed mild symptoms,
the appearance of the CT scan changed accordingly. In the
early publication by Shi and colleagues from Wuhan, 93%
of the 15 preclinical patients had GGO on the chest CT [18].
In the homogenous cohort of Princess Diamond cruise
ship, 73% of the 104 infected patients were asymptomatic.
Table 1 Sensitivity, specificity, and accuracy of chest CT. RT-PCR gold standard
Publication Country Confirmed cases/1M* Sensitivity Specificity Accuracy Sample size Days from symptom onset
[4] Ai T et al China 19.49 97% 25% 68% 1014 N.R.
[5] Wu, J. et al China 31.07 95% N.A. 80 7 ± 4
[6] Himoto, Y. et al Japan 6.9 67–83% 93–80% 86–81% 21 4-26
[7] Cheng, Z. et al China 19.49 100% 25% 47% 38 1–9
[8] Caruso, D. et al Italy 18.66 97% 56% 72% 158 N.R.
N.R. not reported, N.A. not applicable
*Prevalence data from https://ourworldindata.org/coronavirus at the time of data collection reported in the referenced papers
Table 2 Sensitivity, specificity,
and accuracy of RT-PCR accord-
ing to the “reverse calculation”
approach
Publication Sensitivity Specificity Accuracy Sample size Days from symptom onset
[4] Ai, T. et al 65% 83% 67% 1014 N.R.
[7] Cheng, Z. et al 47% 100% 65% 38 1–9
[8] Caruso, D. et al 58% 96% 72% 158 N.R.
N.R. not reported
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Fifty-four percent of these asymptomatic patients had lung
opacities on chest CT. Asymptomatic cases showed more
GGO than symptomatic patients, in whom the most frequent
finding was consolidation [19].
Feasibility of chest CT for screening COVID-19
infection
COVID-19 pandemic is spreading around the world with un-
precedented speed. In this situation, it is important to analyze
the available data to provide guidelines. From the studies we
have reviewed above, it is clear that the chest CT has a high
sensitivity to detect COVID-19. It seems, however, that while
the identification of the virus RNA is the unanimous proof of
the disease, the RT-PCR approach is not able to detect all the
infections especially in the early phase of the disease. Even
more, some studies suggest that chest CT might be more sen-
sitive in this phase.
On the other hand, most of the studies so far suggested that
the specificity of the chest CT is low. But it was compared with
the performance of the RT-PCR, what is known to have a
modest sensitivity. By selecting an inappropriate ground truth
and consequently the number of true positives and negatives are
being unknown, the calculation of performance will be errone-
ous. This fault in the literature was indicated by those studies
which showed that multiple RT-PCR tests are increasing the
detection rate of the disease. The higher specificity of chest CT
was also showed by studies in which COVID-19 and other viral
pneumonias were judged, by expert radiologists [12].
It also has to be seen that the specificity of chest CT is not
as high as it is indicated by our above presented reverse cal-
culation, because the ground truth is not known. But it is
expected to be between the values presented earlier and the
values from our reverse calculation.
To judge the feasibility of chest CT in COVID-19 screening,
other factors have to be considered. In the use of chest CT as a
first-line screening tool in large population, the risk-benefit ratio
should be considered. Medical imaging is the largest man-made
source of exposure that is about 0.6 mSv/year [20]. A standard-
dose chest CT is in the range of 1.8 mSv, but low-dose protocol
was shown to be effective identifying COVID-19 infection that
has a dose about 0.2 mSv [21]. Introducing chest CT on a large-
scale in the diagnosis of COVID-19would increase the radiation
exposure of the population significantly.
It also has to be considered whether the chest CT could
increase the risk of transmission of the disease. With dedicated
protection devices, the execution of the examination should not
carry a higher risk for the medical staff than the risk during the
swab test. With careful cleaning and appropriate air exchange
rate, the nosocomial transmission of the disease can be avoided.
Importantly, CT suits with usual 6–8 air changes per hour
require 35–45 min for airborne-contaminant removal with
99% efficiency. Similar time is needed for cleaning, making
the throughput of a CT suit to 1–2 patients per hour.
Importantly, in regions where the prevalence of the disease
is low, the introduction of chest CT into the screening protocol
might not be warranted, since the relatively high specificity
might only be true for regions with high occurrence of the
disease. Moreover, this could certainly increase the unneces-
sary radiation exposure of the population.
After a careful consideration of the sensitivity, specificity,
the risk of radiation exposure, and the throughput rate of chest
CT and RT-PCR:
& We advise not to use chest CT as a sole diagnostic ap-
proach for COVID-19 infection.
& However, we think the use of chest CT in patients with
typical clinical symptoms in highly infected regions or
with close contact of COVID-19-infected patients who
had negative RT-PCR result is warranted.
& The risk of radiation exposure probably outweighs the
sensitivity of chest CT in asymptomatic patients.
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